Table 2

Effect of treatment group and gestational diabetes mellitus (GDM) on pregnancy outcomes

No GDM (WHO criteria)GDM (WHO criteria)p Value*
Exercise (n=169)Control (n=157)Exercise (n=41)Control (n=61)
Birth weight (g)3,200±4423,191±4703,204±4703,429±427**0.025
Gestational age (days)277±12276±10276±11279±80.137
Caesarean delivery (n, %)24 (14.2)28 (17.8)9 (22)17 (27.9)0.934
Maternal weight gain (kg)11.8±3.613.3±4.3****11.2±4.113.3±3.7***0.536
Apgar score 1 min8.8±1.48.6±1.48.8±1.38.9±1.20.347
Apgar score 5 min9.9±0.49.9±0.49.8±0.710±1.20.10
No GDM (IADPSG criteria)GDM (IADPSG criteria)
Exercise (n=181)Control (n=186)Exercise (n=29)Control (n=32)
Birth weight (g)3,204±4443,218±4653,180±4653,482±437***0.022
Gestational age (days)277±10277±11280±7277±110.261
Caesarean delivery (n, %)27 (14.9)36 (19.4)6 (20.7)9 (28.1)0.891
Maternal weight gain (kg)11.7±3.713.3±4.2****11.6±4.113.4±3.80.902
Apgar score 1 min8.8±1.48.6±1.48.9±1.18.9±0.20.668
Apgar score 5 min9.8±0.59.9±0.89.8±0.59.9±0.80.768
  • *p for treatment (group)×GDM interaction.

  • **p<0.05 vs exercise group.

  • ***p<0.01 vs exercise group.

  • ****p<0.001 vs exercise group.

  • WHO criteria when 2 h 75 g oral glucose tolerance test (‘2 h glucose’) ≥140 mg/dl. GDM International Association for Diabetes in Pregnancy Study Group (IADPSG) criteria when 2 h glucose ≥153 mg/dl.